AndreaBozzo/ceres-open-data-index huggingface dataset:
Summary Safety Review - Antidepressants - Assessing the Potential Risk of Serious Eye Disorder (Angle-Closure Glaucoma)

Health Canada carried out this safety review when it became aware that the FDA was investigating the risk of angle-closure glaucoma linked to antidepressant use. Angle-closure glaucoma is a serious eye disorder where eye fluid drainage is blocked, leading to a sudden increase in the pressure in the eye and causing pain and blurred vision. If not treated immediately, angle-closure glaucoma can lead to permanent vision loss.

Organization: Health Canada | Santé Canada
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

Health Canada reviewed the potential risk of DRESS with the use of atypical antipsychotics, following the manufacturers’ voluntary update of the product safety information for Zyprexa (olanzapine) and Zeldox (ziprasidone) to include the risk of DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms). DRESS describes a group of rare but serious and potentially life-threatening side effects to medications, such as fever, severe skin rash with swollen face or peeling of the skin over large areas of the body, etc.

Organization: Health Canada | Santé Canada
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Sleep Apnoea

Health Canada carried out a safety review to look into the risk of sleep apnoea with the use of atypical antipsychotics. Sleep apnoea is a disorder that causes breaks in breathing or shallow breaths during sleep. This review was triggered by the submission of new safety information from the manufacturer of quetiapine (Seroquel) that included cases of sleep apnoea in patients using quetiapine. 

Organization: Health Canada | Santé Canada
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of sleep walking and sleep-related eating disorder

Health Canada reviewed the potential risk of SW and SRED with the use of atypical antipsychotics, following the publication of a case report describing these events in a patient treated with ziprasidone. Sleep walking is a sleep disorder that causes people to get up and walk or do other complex actions while asleep. Sleep-related eating disorder is a variant of SW in which people get up frequently to eat and drink while asleep. 

Organization: Health Canada | Santé Canada
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Urinary Retention

Health Canada carried out a safety review to look into the use of atypical antipsychotics and the potential risk of having difficulty urinating or not being able to fully empty the bladder (urinary retention). This can be an emergency that requires medical attention. This review was triggered by new safety information received from the manufacturer of Seroquel (quetiapine) that included reports of urinary retention in patients using quetiapine. 

Organization: Health Canada | Santé Canada
Summary Safety Review - AUBAGIO (teriflunomide) - Assessing the potential risk of inflammation of the colon (colitis)

Health Canada reviewed the potential risk of colitis with Aubagio use after finding reports (since being marketed) of colitis as part of routine review of information received from the manufacturer. Also, the product safety information of a closely-related drug, Arava (leflunomide) was updated to include a new warning for colitis. In Canada, the product safety information for Aubagio does not mention the risk of colitis.

Organization: Health Canada | Santé Canada
Summary Safety Review - Benzodiazepines and barbiturates - Assessing the potential risk of negative effects on the development of children’s brains (neurodevelopmental disorders)

The Canadian product safety information for lorazepam and midazolam warn that they should not be used during pregnancy. The Canadian product safety information for phenobarbital warns that during pregnancy the drug’s benefit should be weighed against its risk. Also, restrictions for use in children vary from one drug to another.

Organization: Health Canada | Santé Canada
Summary Safety Review - Bisphosphonates - Assessing the Potential Risk of Severe Bone Damage (osteonecrosis)

Health Canada reviewed the potential risk of severe bone damage (osteonecrosis) with bisphosphonate use because of product information updates in Europe that warn about the risk of severe bone damage in the outer part of the ear canal. Previously, Health Canada completed a safety review of the risk of severe jawbone damage associated with bisphosphonate use. Therefore, the current safety review focused on severe bone damage other than to the jawbone.

Organization: Health Canada | Santé Canada
Summary Safety Review - Breast Implants - Assessing the potential risk of cancer (Breast implant associated-anaplastic large cell lymphoma)

Health Canada has completed a safety review on the potential risk of BIA-ALCL, following an increase in the number of cases reported internationally. The review analysed the available information on the Canadian rate of BIA-ACL (the number of confirmed cases of BIA-ALCL reported in relation to the number of implants sold in Canada over the past 10 years).

Organization: Health Canada | Santé Canada
Summary Safety Review - Celecoxib - Assessing the Risk of Serious Heart and Stroke Side Effects at High Doses Relative to Other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Health Canada carried out a safety review of all the available evidence to evaluate the risk of side effects related to heart and stroke linked with celecoxib, in comparison to other NSAIDs (diclofenac, ibuprofen, naproxen).

Organization: Health Canada | Santé Canada
Summary Safety Review - Clozapine - Assessing the effectiveness of monitoring for low numbers of white blood cells

Clozapine is a prescription drug authorized for sale in Canada to manage symptoms of schizophrenia when other drugs have not helped. Clozapine was developed in the 1960s. In 1975, clozapine was removed from the Canadian market because of reports of life-threatening infections and deaths linked with low numbers of white blood cells (i.e., agranulocytosis). Clozapine was re-introduced to the Canadian market in 1991, but patients must be enrolled in a patient registry program to monitor their white blood cell levels before their next prescription can be filled.

Organization: Health Canada | Santé Canada
Summary Safety Review - CODEINE PRESCRIPTION PRODUCTS Indicated for Cough - Further Assessing the Risk of Serious Breathing Problems in Children and Adolescents

Codeine is converted to morphine in the liver. Some people have genetic variations of liver enzymes which cause codeine to be converted to morphine faster and more completely than in other people. These people with genetic differences (ultra-rapid metabolizers) are more likely to have higher than normal amounts of morphine in their blood after taking codeine. High levels of morphine can result in breathing difficulty, which may cause death. 

Organization: Health Canada | Santé Canada
Summary Safety Review - Codeine-containing products - Further Assessing the Risk of Serious Breathing Problems in Children and Adolescents

In 2013 and 2015, Health Canada carried out safety reviews on codeine-containing products as they relate to the risk of potentially life-threatening breathing problems. At the time, it was recommended that codeine-containing products no longer be used in children under 12 years of age. New safety reviews were carried out to further assess the risk of serious breathing problems in children and adolescents treated with codeine to decide if more should be done to manage this risk in this age group.

Organization: Health Canada | Santé Canada
Summary Safety Review - Denosumab (Prolia and Xgeva) - Hearing loss and deafness

A safety review was carried out after Health Canada received a report from the European Medicines Agency, which linked hearing loss and deafness to the use of Prolia and Xgeva. After review of the report, Health Canada determined that there is not enough information to make such a link. The risk of hearing loss or deafness is already listed in the prescribing information for Xgeva (less common side effect for people with advanced bone cancer), but not for Prolia.

Organization: Health Canada | Santé Canada
Summary Safety Review - DICLECTIN (doxylamine and pyridoxine combination) - Assessing Safety in pregnancy

Diclectin is a drug authorized in Canada to treat nausea and vomiting in pregnancy (i.e. morning sickness). The safety of Diclectin was recently reviewed by Health Canada as part of its routine health product monitoring. Public interest was also raised by recent media reports on Diclectin.

Organization: Health Canada | Santé Canada
Summary Safety Review - Dipeptidylpeptidase-4 (DPP-4) Inhibitors - Assessing the Potential Risk of Heart Failure

A safety review was carried out by Health Canada to evaluate the increased risk of heart failure with the use of DPP-4 inhibitors as a follow-up to a risk communication released by the U.S. FDA stating that saxagliptin and alogliptin might increase the risk of heart failure, in particular in patients who have other risk factors for heart failure. The product safety information in the U.S. and Canada were recently updated to include this risk.

Organization: Health Canada | Santé Canada
Summary Safety Review - Ear and Forehead (contact) Infrared Thermometers (various brands) - Assessing the potential risk of inaccuracy in children under 2 years old

Health Canada reviewed the risk of IR thermometers being inaccurate when checking the temperature of children under 2 years old because of new information that became available. At the time of the review, IR thermometers were not recommended to be used in children under 2 years old. 

Organization: Health Canada | Santé Canada
Summary Safety Review - ESSURE Permanent Birth Control System - Assessing the Risk of Complications and the Potential Need for Device Removal

Health Canada carried out a safety review due to concerns regarding complications associated with the Essure device after it is inserted into the fallopian tubes. In certain cases, the symptoms have led patients to have the Essure device removed, which requires surgical intervention and may include removal of the uterus (hysterectomy).

Organization: Health Canada | Santé Canada
Contiguously Settled Areas: Settlement footprints, 2010 and 2020

This product contains contiguously settled area (CSA) boundaries for a subset of Canadian population centres for 2010 and 2020.  
  
  The CSA boundaries are derived from land cover data and represent the geographic extent of settled areas based on their physical footprint on the landscape. The boundaries can be used for reference, mapping and spatial analysis of settled areas and urban ecosystems.  
  
  The CSA boundaries are created and maintained under the umbrella of the Census of Environment, and will support Statistics Canada’s ecosystem accounting efforts following the System of Environmental-Economic Accounting — Ecosystem Accounting (SEEA EA) framework. The primary purpose of the CSA boundaries is to represent the extent of the contiguous urban footprint and allow for the measurement of settled area expansion over time. They will also contribute to the urban and industrial ecosystem class in Statistics Canada’s ecosystem accounting efforts. The boundaries will be used for other types of urban ecosystem analyses, including measures of urban ecosystem condition and services. The CSA boundaries may also be used for urban thematic accounts or to inform where users of ecosystem services are located.  
  
  Moving forward, CSA boundaries will be updated on an ongoing basis.

Organization: Statistics Canada | Statistique Canada
Concordance Between the Custody Rating Scale (CRS) and Offender Security Level (OSL) Among Men Offenders

Among men offenders, concordance between the Custody Rating Scale (CRS) and actual security classification was 74% for new admissions, and 69% for revocation admissions. The Custody Rating Scale (CRS) is an instrument employed by the Correctional Service of Canada (CSC) to assist in determining an offender’s initial security classification.


Organization: Correctional Service of Canada | Service correctionnel du Canada
Section 84 releases among indigenous offenders released from men's institutions

Community supervision profiles of Section 84 releases for Indigenous offenders released from men's institutions are unique compared to those of non-Section 84 participants. Involving Indigenous communities in the reintegration process of Indigenous offenders, specifically through the Section 84 release process, is fundamental to their success.The present research examines the prevalence of Section 84 releases among Indigenous offenders released from men's institutions, as well as the profiles of Indigenous offenders participating in Section 84 releases in comparison to those who did not. 


Organization: Correctional Service of Canada | Service correctionnel du Canada
Section 84 releases among indigenous offenders released from women's sites

Currently, about one-third of all Indigenous offenders released from women's institutions participated in Section 84 releases; participation rates did not appear to be impacted by the COVID-19 pandemic. The current study examines the prevalence of Section 84 releases for Indigenous offenders released from women's institution and compares the profile of Section 84 participants to non-participants.


Organization: Correctional Service of Canada | Service correctionnel du Canada
Ecosystem Sites, Gaseous Nitrogen and Sulphur Species, Oil Sands Region

Environment and Climate Change Canada (ECCC) began ambient air monitoring of several nitrogen and sulphur species southeast of the Athabasca oil sands region in February 2015. Continuous measurements of NO, NO2, NOy, NH3, and SO2 are currently being conducted at two sites in Saskatchewan. Measurements began at Pinehouse Lake, SK in February 2015 and at Flat Valley, SK in February 2016. Both sites are approximately 350 km southeast of the Athabasca oil sands region and are sited to study long range transport and deposition of pollutants.

In addition to these continuous nitrogen and sulphur measurements, the Canadian Air and Precipitation Monitoring Network (CAPMoN) measures ground-level ozone, ambient particles and gases, and precipitation chemistry at both sites. These supporting CAPMoN measurements will enable the assessment of overall dry and wet deposition of nitrogen and sulphur.

The measurement data indicate that concentrations of these nitrogen and sulphur species are comparable to those of other rural/remote locations across Canada. Concentrations of NO, NO2, NOy, and SO2 are occasionally impacted by air masses with slightly elevated pollutant levels. The reported NO2 or SO2 concentrations have not exceeded either the Canadian Ambient Air Quality Standards (CAAQS) or Saskatchewan Ambient Air Quality Standards. 

Data may be used together with modelled air mass back trajectories to estimate the relative contribution of emission sources to total deposition of nitrogen and sulphur at sensitive ecosystems downwind of the oil sands, assist in the development and evaluation of chemical transport models, and validate satellite observations of NO2, NH3 and SO2.

Organization: Environment and Climate Change Canada | Environnement et Changement climatique Canada
Average employment income indicators, by groups designated as visible minorities and selected sociodemographic characteristics for the population aged 15 years and over in private households, 2006, 2011 and 2016, inactive

Average employment income and average weekly earnings, by groups designated as a visible minorities and selected sociodemographic characteristics (sex, age group, first official language spoken, immigrant status, period of immigration, generation status and highest certificate, degree or diploma) for the population who worked during the reference year and aged 15 years and over in private households, 2006,2011 and 2016.<br>

Organization: Statistics Canada | Statistique Canada
Canada's National Earthquake Scenario Catalogue - Georgia Strait Fault - Magnitude 5.0

In 1997, a magnitude 4.6 earthquake occurred 3 to 4 km beneath the Strait of Georgia, near Vancouver. This scenario visualizes the effects of that event if it occurred today with a magnitude of 5.0. A magnitude 7.0 Georgia Strait scenario is also provided, and represents a less likely but more consequential case for comparison.

Organization: Natural Resources Canada | Ressources naturelles Canada
Canada's National Earthquake Scenario Catalogue - Beaufort Fault - Magnitude 5.2

The Beaufort fault in Eastern Vancouver Island is probably an active fault, near Courtenay/Comox/Cumberland. Based on current science, this fault may have ruptured in the 1946 magnitude 7.3 Vancouver Island Earthquake. This scenario represents a smaller magnitude 5.2 event.

Organization: Natural Resources Canada | Ressources naturelles Canada
Canada's National Earthquake Scenario Catalogue - Queen Charlotte Fault - Magnitude 8.0

In 1949 a magnitude 8.1 earthquake occurred on the Queen Charlotte Fault, off the west coast of the Haida Gwaii archipelago. This magnitude 8.0 scenario along the Queen Charlotte Fault is slightly different and closer to population centres than the magnitude 7.8 earthquake that occurred in 2012.

Organization: Natural Resources Canada | Ressources naturelles Canada
[ARCHIVED] Nova Scotia Lidar Point Cloud All Hits New Glasgow 2014

[ARCHIVED] This dataset has been archived as it is no longer able to be provided in this manner. For a more current version of this elevation dataset, please refer to https://nsgi.novascotia.ca/datalocator/elevation/ to access the current catalogue of available elevation products. Elevation data (LiDAR) was captured for a select group of 1:2000 scale map sheets covering the Town of New Glasgow. This LiDAR data has not been classified and is a raw data record of all the returns from the LiDAR sensor. The nominal point spacing of the returns is 1 point per metre. The area collected is a total of eleven 1:2000 scale map sheet windows for a total coverage of approximately 31 square kilometres.

Organization: Government of Nova Scotia | Gouvernment de la Nouvelle-Écosse
[ARCHIVED] Nova Scotia Lidar Point Cloud Ground Classified Shelburne 2013

[ARCHIVED] This dataset has been archived as it is no longer able to be provided in this manner. For a more current version of this elevation dataset, please refer to https://nsgi.novascotia.ca/datalocator/elevation/ to access the current catalogue of available elevation products. Elevation data (LiDAR) was captured for a select group of 1:2000 scale map sheets covering the Town of Shelburne. This LiDAR data has had all ground points classified thereby providing a bare earth profile for the project area. The nominal point spacing of the returns is 1 point per metre. The area collected is a total of six 1:2000 scale map sheet windows for a total coverage of approximately 17 square kilometres.

Organization: Government of Nova Scotia | Gouvernment de la Nouvelle-Écosse
[ARCHIVED] Nova Scotia Lidar Point Cloud Ground Classified Eskasoni MiKmaw Nation 2012

[ARCHIVED] This dataset has been archived as it is no longer able to be provided in this manner. For a more current version of this elevation dataset, please refer to https://nsgi.novascotia.ca/datalocator/elevation/ to access the current catalogue of available elevation products. Elevation data (LiDAR) was captured for a select group of 1:2000 scale map sheets covering Eskasoni Mi’Kmaw Nation Reserve. This LiDAR data has had all ground points classified thereby providing a bare earth profile for the project area. The nominal point spacing of the returns is 1 point per metre. The area collected is a total of thirteen 1:2000 scale map sheet windows for a total coverage of approximately 36 square kilometres.

Organization: Government of Nova Scotia | Gouvernment de la Nouvelle-Écosse
[ARCHIVED] Nova Scotia 1m DEM New Glasgow 2014

[ARCHIVED] This dataset has been archived as it is no longer able to be provided in this manner. For a more current version of this elevation dataset, please refer to https://nsgi.novascotia.ca/datalocator/elevation/ to access the current catalogue of available elevation products. The Nova Scotia Elevation Dataset, consisting of a Digital Elevation Model (DEM) derived from LiDAR data is available for select 1:2000 scale map sheet windows covering the Town of New Glasgow. The DEM is a bare earth rasterized elevation model with a one metre cell size. The area collected is a total of eleven 1:2000 scale map sheet windows for a total coverage of approximately 31 square kilometres.

Organization: Government of Nova Scotia | Gouvernment de la Nouvelle-Écosse
[ARCHIVED] Nova Scotia 1m DEM Lockeport 2013

[ARCHIVED] This dataset has been archived as it is no longer able to be provided in this manner. For a more current version of this elevation dataset, please refer to https://nsgi.novascotia.ca/datalocator/elevation/ to access the current catalogue of available elevation products. The Nova Scotia Elevation Dataset, consisting of a Digital Elevation Model (DEM) derived from LiDAR data is available for select 1:2000 scale map sheet windows covering the Town of Lockeport. The DEM is a bare earth rasterized elevation model with a one metre cell size. The area collected is a total of five 1:2000 scale map sheet windows for a total coverage of approximately 14 square kilometres.

Organization: Government of Nova Scotia | Gouvernment de la Nouvelle-Écosse
[ARCHIVED] Nova Scotia Lidar Point Cloud All Hits Shelburne District 2013

[ARCHIVED] This dataset has been archived as it is no longer able to be provided in this manner. For a more current version of this elevation dataset, please refer to https://nsgi.novascotia.ca/datalocator/elevation/ to access the current catalogue of available elevation products. Elevation data (LiDAR) was captured for a select group of 1:2000 scale map sheets located in the District of the Municipality Of Shelburne. This LiDAR data has not been classified and is a raw data record of all the returns from the LiDAR sensor. The nominal point spacing of the returns is 1 point per metre. The area collected is a total of thirty four 1:2000 scale map sheet windows for a total coverage of approximately 95 square kilometres.

Organization: Government of Nova Scotia | Gouvernment de la Nouvelle-Écosse
[ARCHIVED] Nova Scotia 1m DEM Eskasoni MiKmaw Nation 2012

[ARCHIVED] This dataset has been archived as it is no longer able to be provided in this manner. For a more current version of this elevation dataset, please refer to https://nsgi.novascotia.ca/datalocator/elevation/ to access the current catalogue of available elevation products. The Nova Scotia Elevation Dataset, consisting of a Digital Elevation Model (DEM) derived from LiDAR data is available for select 1:2000 scale map sheet windows covering the Eskasoni Mi’Kmaw Nation Reserve. The DEM is a bare earth rasterized elevation model with a one metre cell size. The area collected is a total of thirteen 1:2000 scale map sheet windows for a total coverage of approximately 36 square kilometres.

Organization: Government of Nova Scotia | Gouvernment de la Nouvelle-Écosse
Canada's National Earthquake Scenario Catalogue - Queen Charlotte Fault - Magnitude 7.7

In 1949 a magnitude 8.1 earthquake occurred on the Queen Charlotte Fault, off the west coast of the Haida Gwaii archipelago. This magnitude 7.7 scenario along the Queen Charlotte Fault is slightly different and closer to population centres than the magnitude 7.8 earthquake that occurred in 2012.

Organization: Natural Resources Canada | Ressources naturelles Canada